Bristol-Myers Squibb (BMY) Has Climbed To A New High Following Upgrade

Citigroup upgraded its rating on shares of Bristol-Myers Squibb (BMY) Wednesday morning to "Buy" from "Neutral."

Bristol-Myers Squibb gapped open higher Wednesday and has continued to rise in early trade. The stock is now up 2.25 at $46.31 and has climbed to a new high for the year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com